Select for export Psychedelic science in post-COVID-19 psychiatry Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/ipm.2020.94 PubMed 32811575 Copy citation Copy BibTeX Irish Journal of Psychological Medicine 2020-08-18 John R. Kelly, Matthew Crockett, Laith Alexander, Martin Haran, Amanda Baker, Lisa M. Burke OpenAlex Published psilocybin DepressionAddictionMechanism of Action Clinical Trial More
Select for export Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid Release Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2020.08.12.248229 Copy citation Copy BibTeX bioRxiv 2020-08-13 Jones NT, Zahid Z, Grady SM, Sultan ZW, Zheng Z, Banks MI bioRxiv PREPRINT (not peer reviewed) psilocybin AnxietyMechanism of ActionAnimal Study Animal Study More
Select for export How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2020.06.09.142802 Copy citation Copy BibTeX bioRxiv 2020-06-10 Hirschfeld T, Schmidt TT. bioRxiv PREPRINT (not peer reviewed) psilocybin ConsciousnessMystical ExperienceMeta-Analysis Meta-Analysis More
Select for export Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2019.107933 PubMed 31917152 Copy citation Copy BibTeX Neuropharmacology 2020-04-30 Halberstadt AL, Chatha M, Klein AK, Wallach J, Brandt SD PubMed Published psilocybin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export Pharmacokinetics of Psilocybin in Normal Adult Volunteers Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2020-04-14 University of Wisconsin, Madison ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpdd.796 PubMed 32250059 Copy citation Copy BibTeX Clinical Pharmacology in Drug Development 2020-04-05 Elyes Dahmane, Paul R. Hutson, Jogarao Gobburu OpenAlex Published psilocybinpsilocin DepressionPharmacologyReceptor Pharmacology Clinical Trial More
Select for export One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1096/fasebj.2020.34.s1.02912 Copy citation Copy BibTeX The FASEB Journal 2020-03-31 Meghan Hibicke, Charles D. Nichols OpenAlex Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Other More
Select for export Long-Term Analysis of Psilocybin in Cancer Patients With Distress Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/01.cot.0000660232.19098.7f Copy citation Copy BibTeX Oncology Times 2020-03-25 Richard Simoneaux OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding No abstract availability was recorded for this entry. Details DOI 10.1016/j.euroneuro.2020.02.001 PubMed 32146028 Copy citation Copy BibTeX European Neuropsychopharmacology 2020-03-03 M. Madsen, Patrick M. Fisher, Dea Siggaard Stenbæk, Sara Kristiansen, Daniel Burmester, Szabolcs Lehel OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881120908004 PubMed 32108529 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-02-27 Daniel Rosenbaum, Cory R. Weissman, Thomas Anderson, Rotem Petranker, Lê-Anh Dinh-Williams, Katrina Hui OpenAlex Published psilocybin AnxietyAddictionMicrodosing Randomized Controlled Trial More
Select for export Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/biomedicines8020034 PubMed 32085521 Copy citation Copy BibTeX Biomedicines 2020-02-17 Candace R. Lewis, Katrin H. Preller, B. Blair Braden, Cory Riecken, Franz X. Vollenweider OpenAlex Published psilocybinpsilocin Brain ImagingReceptor PharmacologyConsciousness Other More
Select for export Emotions and brain function are altered up to one month after a single high dose of psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-020-59282-y PubMed 32042038 Copy citation Copy BibTeX Scientific Reports 2020-02-09 Frederick S. Barrett, Manoj K. Doss, Nathan D. Sepeda, James J. Pekar, Roland R. Griffiths OpenAlex Published psilocybin AnxietyAddictionNeuroplasticity Other More
Select for export Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2019.00955 PubMed 32038317 Copy citation Copy BibTeX Frontiers in Psychiatry 2020-01-21 Albert Garcia-Romeu, Alan K. Davis, Earth Erowid, Fire Erowid, Roland R. Griffiths, Matthew W. Johnson OpenAlex Published psilocybin AddictionChronic PainReceptor Pharmacology Observational Study More
Select for export Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881119897615 PubMed 31916890 Copy citation Copy BibTeX Journal of Psychopharmacology 2020-01-08 Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, Sarah E. Mennenga, Katherine Ponte, Jeffrey Guss OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export [Microdosing with psychedelics: what do we know?] Abstract available at the source but not redistributed here. Read at source. Details PubMed 32816295 Copy citation Copy BibTeX PubMed 2019-12-31 Kim P. C. Kuypers OpenAlex Published psilocybin AnxietyMicrodosingWellbeing Other More
Select for export Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2019-12-29 Johns Hopkins University ClinicalTrials.gov CLINICAL TRIAL psilocybin Brain ImagingPharmacologyAging Other More
Select for export The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2019.12.023 PubMed 32056741 Copy citation Copy BibTeX Unknown journal 2019-12-13 Mathai DS, Meyer MJ, Storch EA, Kosten TR. Europe PMC Published psilocybin DepressionMechanism of ActionConsciousness Systematic Review More
Select for export Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s12954-019-0333-3 PubMed 31779667 Copy citation Copy BibTeX Harm Reduction Journal 2019-11-27 Martin Andersson, Anette Kjellgren OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Qualitative Study More
Select for export A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis. Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2019-08-12 King's College London ClinicalTrials.gov CLINICAL TRIAL psilocybin Brain ImagingPharmacologyMechanism of Action Other More
Select for export Decreased Directed Functional Connectivity in the Psychedelic State Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/703660 Copy citation Copy BibTeX bioRxiv 2019-07-15 Barnett L, Muthukumaraswamy SD, Carhart-Harris RL, Seth AK. bioRxiv PREPRINT (not peer reviewed) psilocybin Brain ImagingMechanism of ActionAging Other More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.